GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (XPAR:NANO) » Definitions » Cyclically Adjusted PB Ratio

Nanobiotix (XPAR:NANO) Cyclically Adjusted PB Ratio : 5.40 (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Nanobiotix Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Nanobiotix's current share price is €5.83. Nanobiotix's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was €1.08. Nanobiotix's Cyclically Adjusted PB Ratio for today is 5.40.

The historical rank and industry rank for Nanobiotix's Cyclically Adjusted PB Ratio or its related term are showing as below:

XPAR:NANO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.56   Med: 5.48   Max: 13.43
Current: 5.46

During the past 13 years, Nanobiotix's highest Cyclically Adjusted PB Ratio was 13.43. The lowest was 1.56. And the median was 5.48.

XPAR:NANO's Cyclically Adjusted PB Ratio is ranked worse than
80.94% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs XPAR:NANO: 5.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nanobiotix's adjusted book value per share data of for the fiscal year that ended in Dec23 was €-0.039. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.08 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanobiotix Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Nanobiotix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Cyclically Adjusted PB Ratio Chart

Nanobiotix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 11.91 6.09 3.36 6.15

Nanobiotix Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.09 - 3.36 - 6.15

Competitive Comparison of Nanobiotix's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Nanobiotix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanobiotix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanobiotix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nanobiotix's Cyclically Adjusted PB Ratio falls into.



Nanobiotix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nanobiotix's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.83/1.08
=5.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanobiotix's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Nanobiotix's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.039/118.3900*118.3900
=-0.039

Current CPI (Dec23) = 118.3900.

Nanobiotix Annual Data

Book Value per Share CPI Adj_Book
201412 2.157 99.860 2.557
201512 1.103 100.040 1.305
201612 1.090 100.650 1.282
201712 2.238 101.850 2.601
201812 0.726 103.470 0.831
201912 -0.085 104.980 -0.096
202012 2.047 104.960 2.309
202112 0.769 107.850 0.844
202212 -0.776 114.160 -0.805
202312 -0.039 118.390 -0.039

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanobiotix  (XPAR:NANO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nanobiotix Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanobiotix (XPAR:NANO) Business Description

Industry
Traded in Other Exchanges
Address
60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix (XPAR:NANO) Headlines

No Headlines